Search Results

Hillstream BioPharma, Inc. has selected immune-oncology clinical research organization (CRO), OncoBay Clinical , to provide comprehensive clinical and regulatory support for the clinical development program for its lead drug candidate HSB-1216.

OncoBay Clinical Inc., a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership with Protocol First, Inc., a software solutions provider focused on accelerating clinical research.

Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO, reiterates its commitment to advancing clinical research through Technology and Data Integrity by increasing its clinical operations in the US.

AiCure, an AI and data analytics company focused on improving clinical trials, and OncoBay Clinical, a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, today announced a strategic partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.

Health Decisions, Inc. and OncoBay Clinical, Inc. announced a partnership to deliver specialized clinical development services for pharmaceutical and biotechnology companies developing therapeutics, medical devices, and diagnostics in oncology.